In this free webinar, discover how multiplexed, microarray-based technology is transforming cell and gene therapy (CGT) manufacturing by streamlining raw material quality control. Attendees will explore how this innovative approach reduces time and cost constraints while ensuring critical quality attributes (CQAs) are met. The featured speakers will present a case study demonstrating the technology's impact and discuss its broader applications for CGT developers and manufacturers.
TORONTO, Feb. 11, 2025 /PRNewswire-PRWeb/ -- Cell and gene therapies (CGT) are emerging as novel solutions for disease treatment and prevention.
While promising, CGT involve complex manufacturing processes that demand speed due to the nature of the life-threatening diseases that are being treated. A critical aspect of the manufacturing process is the incorporation of effective, rapid analytical tools for qualifying raw materials and assessing product critical quality attributes (CQAs).
Current analytical tools used in CGT manufacturing for incoming raw materials characterization can be time- and labor-intensive, are often non-standardized and represent a bottleneck in the time to manufacture these critical therapies.
In this webinar, the expert speakers will discuss a multiplexed, microarray-based technology that allows for streamlined quantitative analysis of a wide range of target analytes, including proteins, antibodies and nucleic acids. They will also focus on a case study demonstrating how a multiplexed, microarray-based technology can be used for the quality control of incoming raw materials used in CGT. They will also discuss other potential application areas for which the benefits of a simple, rapid multiplexed platform can provide value to CGT developers and manufacturers.
Register for this webinar today to explore how multiplexed, microarray-based technology is revolutionizing cell and gene therapy manufacturing.
Join Randy Lacey, PhD, Field Applications Scientist, InDevR, for the live webinar on Thursday, February 27, 2025, at 10am EST (4pm CET).
For more information, or to register for this event, visit Revolutionizing Raw Material QC Analytics in Cell and Gene Therapy Manufacturing with Multiplexed Microarray Technology.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Soumya Shashikumar, Xtalks, +1 (416) 977-6555 x371, [email protected], https://xtalks.com
SOURCE Xtalks
Share this article